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Previous studies have shown that the gene coding for the Vpu protein of the human immunodeficiency virus type 1 (HIV-1) is 5V to the env
gene, is in a different reading frame, and overlaps the env by 90 nucleotides. In this study, we examined the processing of the Env protein as well
as the maturation and infectivity of a virus (SHIVVpenv) in which a single nucleotide was removed at the vpu–env junction, fusing the first 162
bases of vpu to the envORF. Pulse-chase analysis revealed that SHIVVpenv-infected cells gave rise to two precursor glycoprotein species (gp160
and gp175). Immune precipitation results also revealed that an anti-Vpu serum could immune precipitate the gp175 precursor, suggesting that
the amino-terminal Vpu sequence was fused to the Env protein. Growth curves revealed that the SHIVVpenv-inoculated cultures released
approximately three times more p27 into the culture medium than parental SHIVKU-1bMC33. Electron microscopy revealed that while both
viruses matured at the cell plasma membrane, significantly higher quantities of virus particles were cell associated on SHIVVpenv-infected cells
compared to cultures inoculated with parental SHIVKU-1bMC33. Furthermore, virus was observed maturing into intracellular vesicles of
SHIVVpenv-infected cells. To assess the pathogenicity of SHIVVpenv, three pig-tailed macaques were inoculated with the SHIVVpenv and
monitored for 6 months for CD4+ T cell levels, viral loads, and the stability of the deletion at the vpu–env junction. Our results indicated that
SHIVVpenv caused a severe CD4
+ Tcell loss in all three macaques within weeks of inoculation. Sequence analysis of the vpu gene analyzed from
sequential PBMC samples derived from macaques revealed that this mutation was stable during the period of rapid CD4+ T cell loss. Sequence
analysis showed that with increasing time of infection, the one base pair deletion was repaired in all three macaques inoculated with SHIVVpenv
with the reversion occurring at 10 weeks in macaque CT1G and at 12 weeks in macaque CP3R and CT1R. These results indicate that fusion of
the first 54 amino acids of Vpu to Env results in intracellular maturation of virus, and accumulation of virus within intracellular vesicles as well
as on the cell plasmamembrane. Our results indicate that while fusion of the vpu gene to env results in a virus that is still pathogenic for pig-tailed
macaques, there is a selective pressure to maintain the vpu and env genes in separate reading frames.
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D.R. Hout et al. / Virology 323 (2004) 91–10792Introduction nucleotide, we have kept the env initiation signal in theThe Vpu protein is a small membrane-bound protein that
is translated from a bicistronic mRNA that also encodes the
envelope glycoprotein precursor (Schwartz et al., 1990).
Previous studies have shown that the Vpu protein has at
least two functions within HIV-1-infected cells. One of these
functions involves the interaction of Vpu with the CD4
molecule resulting in CD4 re-translocation across the mem-
brane and shunting this protein to the proteasome for
degradation (Fujita et al., 1997; Schubert et al., 1998). This
function has been associated with the cytoplasmic domain
of Vpu (Schubert et al., 1996a). Phosphorylation at the two
casein kinase II sites and the a-helical regions of the
cytoplasmic domain have been shown to be essential for
this function of Vpu (Paul and Jabbar, 1997; Schubert et al.,
1992). The second function attributed to Vpu is the ability to
enhance virion release from infected cells. While the mech-
anism of the enhanced release is unknown, some studies
have associated this property with the transmembrane do-
main of Vpu (Paul et al., 1998; Schubert et al., 1996b). The
transmembrane domain of Vpu has been shown to have
properties of an ion channel (Ewart et al., 1996; Schubert et
al., 1996b) and in a recent study it was shown that amiloride
derivatives were able to block this ion channel and virion
release (Ewart et al., 2002).
The Vpu protein has also been shown to enhance the
pathogenicity of simian human immunodeficiency virus
(SHIV) in macaques. We have shown that during the
derivation of pathogenic SHIV from the non-pathogenic
SHIV-4, reversion of the first codon of vpu from ACG to
AUG (and hence coding for a functional protein) was
associated with increased replication (McCormick-Davis et
al., 1998). Using a pathogenic molecular clone of SHIV, we
subsequently showed that an intact vpu contributed to the
CD4+ T cell loss that occurs during infection with the
pathogenic SHIV (Stephens et al., 2002) and that disease
in macaques only occurred if compensating substitutions
occurred in the env and nef (McCormick-Davis et al., 2000;
Singh et al., 2001).
The translation of downstream open reading frames
(ORF) on bicistronic mRNA usually involves a leaky
scanning mechanism with the upstream AUG not in the
optimal context for translation initiation. Previous studies
have suggested that expression of the HIV-1 Env protein
requires a weak vpu translation initiation signal, which
enables ribosomes to use a leaky scanning mechanism to
access downstream env ORF (Schwartz et al., 1990). Evi-
dence for this comes from the observation that the expres-
sion of downstream ORFs are inhibited in mRNAs that
contain the tat ORF, which contains a strong signal for
translation initiation. Because the vpu and env genes are in
different ORFs on the same mRNA, we have taken advan-
tage of this property by removing a single nucleotide at the
vpu–env junction to analyze the initiation of translation of
the Vpu and Env proteins. Thus, by removing this singlesame context as the parental virus. By the construction of
such a virus, we believe that the translation of Vpu and Env
proteins can be more accurately assessed. Our results
indicate that a simian human immunodeficiency virus
(SHIV) expressing this mutation synthesizes approximately
equal amounts of Vpu–Env precursor and Env precursors
and increased amounts of virus is associated with the cell
plasma membrane. These results indicate that fusion of the
vpu sequences to the env can overcome the requirement of
an intact Vpu for enhanced virion release, possibly by
shunting virus maturation to intracellular sites.Results
Deletion of a single nucleotide at the vpu–env junction
results in the equal synthesis of two envelope precursor
proteins
Cultures of C8166 cells were inoculated with parental
SHIVKU-1bMC33 or SHIVVpenv for 5 days, cells radio-
labeled, and SHIV proteins immune precipitated from
the culture medium and cell lysates using an a-SHIV
serum. As shown in Fig. 1, SHIV proteins immune
precipitated from SHIVKU-1bMC33-infected cells included
the Env precursor gp160, the gp120 Env cleavage prod-
uct, the Gag precursor (p57) and the major Gag cleavage
product p27. Immune precipitation of SHIV proteins from
SHIVVpenv-infected cells using an a-SHIV serum revealed
the presence of two Env precursor proteins, gp175 and
gp160, as well as gp120, p57, and p27. Immune precip-
itation of viral proteins from the culture supernatants
revealed that gp120 was released into the medium but
not gp160 or gp175. We hypothesized that if the gp175
precursor was inserted into the membrane via the Vpu
signal sequence (which is an uncleaved signal sequence)
that it should be immune precipitated with an a-Vpu
serum. The results in Fig. 2 show that the gp175 protein
could be immune precipitated from SHIVVpenv. Together,
these results indicate that removal of a single nucleotide
(A) at the vpu–env junction resulted in the biosynthesis
of two Env precursor proteins, one of which has an
uncleaved signal sequence. The results also suggest that
the gp175 is not incorporated into maturing virus
particles.
Pulse-chase analysis reveals a similar release of viral
proteins from SHIVVpenv- and SHIVKU-1bMC33-infected cells
To determine the stability of the Vpu–Env precursor
in SHIVVpenv-infected cells, C8166 cells were inoculated
with SHIVKU-1bMC33 or SHIVVpenv for 5 days followed
by pulse-chase analyses (Fig. 3). Fig. 3A shows normal
synthesis and processing of precursor proteins from
parental SHIVKU-1bMC33 and Fig. 3B shows the
D.R. Hout et al. / Virology 323 (2004) 91–107 93SHIVKU-1bMC33 proteins released into the culture medium.
As shown in Fig. 3B, the Gag proteins were released into
the culture medium starting at the 1 h chase period,
which was similar to what we have previously reported
(McCormick-Davis et al., 2000; Stephens et al., 2002).
The results of the pulse-chase analysis of SHIVVpenv-
infected cells are shown in Figs. 3C and D. As shown in
Fig. 3C, the two precursor proteins were synthesized in
roughly equivalent levels and densitometry revealed that
the precursors were in equivalent amounts at the 1, 2, 4,Fig. 2. Immune precipitation of Vpu proteins from SHIVKU-1bMC33- and
SHIVVpenv-inoculated cultures. C8166 cultures were inoculated with
SHIVKU-1bMC33 or SHIVVpenv at an MOI of approximately 0.01. Cultures
were incubated for 5 days and then radiolabeled with 35S-methionine/
cysteine for 5 h. Vpu proteins were immune precipitated from cell lysates
using an a-Vpu serum as described in the Materials and methods section.
All samples were analyzed under reducing conditions by SDS-PAGE
(12.5% gel) and visualized by standard autoradiographic techniques.
(Lane 1) Vpu proteins immune precipitated from SHIVVpenv-inoculated
cultures. (Lane 2) Vpu proteins immune precipitated from SHIVKU-1bMC33-
inoculated cultures. (Lane 3) Vpu proteins immune precipitated from
uninoculated cultures. The location of the molecular weight markers is
shown on the right.and 6 h chase periods (data not shown). The gp175
precursor appeared to be processed with kinetics that
were similar to the gp160 precursor. Exposure of gelsFig. 1. Immune precipitation of SHIV proteins from SHIVKU-1bMC33 and
SHIVVpenv-inoculated cultures. C8166 cultures were inoculated with
SHIVKU-1bMC33 or SHIVVpenv at an MOI of approximately 0.01. Cultures
were incubated for 5 days and then radiolabeled with 35S-methionine/
cysteine for 5 h. SHIV proteins were immune precipitated from cell lysates
as described in the Materials and methods section. All samples were
analyzed under reducing conditions by SDS-PAGE (10% gel) and
visualized by standard autoradiographic techniques. (Panel A) Immune
precipitation of SHIV proteins from the cell lysates. (Lane 1) Immune
precipitation of SHIV proteins from uninoculated C8166 cells. (Lane 2)
Immune precipitation of SHIV proteins from C8166 cells inoculated with
SHIVVpenv. (Lane 3) Immune precipitation of SHIV proteins from C8166
cells inoculated with SHIVKU1-bMC33. (Panel B) Immune precipitation of
SHIV proteins from the culture medium. (Lane 1) Immune precipitation of
SHIV proteins from uninoculated C8166 cells. (Lane 2) Immune
precipitation of SHIV proteins from C8166 cells inoculated with
SHIVVpenv. (Lane 3) Immune precipitation of SHIV proteins from C8166
cells inoculated with SHIVKU1-bMC33. The location of the molecular weight
markers is shown on the left.
Fig. 3. Pulse-chase analysis of the synthesis and processing of SHIV proteins from SHIVKU-1bMC33- and SHIVVpenv-inoculated cultures. Cultures of C8166
cells were inoculated with SHIVKU-1bMC33 or SHIVVpenv as described in the Materials and methods. At 5 days post-infection, infected cells were starved for
methionine for 2 h and then pulse labeled with 1 mCi of 35S-methionine and cysteine for 1 h. The medium containing the radiolabel was removed, washed once
with medium containing 100 cold methionine and cysteine, and the radiolabel chased in the same medium for various periods of time (0, 1, 2, 4, and 6 h). The
culture medium was collected and cell lysates prepared as described in the text. SHIV-specific proteins were immune precipitated using a pooled serum
from four macaques that had been infected with non-pathogenic SHIV for 6 months. SHIV-specific proteins from the cell lysates from SHIVKU-1bMC33-
inoculated and SHIVVpenv-inoculated C8166 cultures are shown in Panel A and C, respectively. SHIV-specific proteins from the culture medium from
SHIVKU-1bMC33-inoculated and SHIVVpenv-inoculated C8166 cultures are shown in Panel B and D, respectively. Uninfected C8166 cells, radiolabeled and
chased for 6 h served as a negative control (lane C). All samples were analyzed under reducing conditions by SDS-PAGE (10% gel) and visualized by
standard autoradiographic techniques.
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gp120 protein appeared with similar kinetics in the pulse-
chase analysis of SHIVKU-1bMC33- and SHIVVpenv-inocu-Fig. 4. Growth curves of SHIVKU-1bMC33 and SHIVVpenv in C8166 cells. Cultures
described in the text. Aliquots of the culture medium were assayed for the presence
shown with the error bars).lated cultures (data not shown). As shown in Fig. 3D,
viral Gag proteins were detected in the culture medium
beginning at the 1 h chase period. These results indicateof C8166 cells were inoculated with either SHIVKU-1bMC33 or SHIVVpenv as
of p27 antigen. The growth curves were performed in triplicate (mean value
Fig. 5. Examination of the SHIVVpenv and SHIVKU-1bMC33 maturation by electron microscopy. C8166 cells were inoculated with equivalent amounts of either
SHIVVpenv or SHIVKU-1bMC33 and at 5 days post-inoculation, cells were processed for electron microscopy. (Panel A) Maturation of SHIVKU-1bMC33 showing
typical maturation at the cell surface. (Panels B–D) Maturation of SHIVVpenv showing virus particles within intracellular vesicles and at the cell surface
vesicles.
Table 1











SHIVKU-1bMC33 100 24 1–94
SHIVVpenv 100 79 12–285
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kinetics that were similar to the parental virus.
Growth curves reveal increased virus release from C8166
cultures inoculated with SHIVVpenv
In addition to pulse-chase analysis, p27 growth curves
were performed to quantify the amount of virus released.
Cultures of C8166 cells were inoculated with equivalent
numbers of infectious units of SHIVKU-1bMC33 or SHIVVpenv
as determined by titration in the HOS-CXCR4 cell line.
Culture fluids were collected at 0, 1, 3, 5, 7, and 10 days
post-inoculation and assayed for p27 released into the culture
medium. As shown in Fig. 4, p27 growth curves revealed a 3-
fold increase in virus released from cultures inoculated with
SHIVVpenv, indicating that the fusion of the vpu to env
increased virus release from cells.
SHIVVpenv is more cytopathic than the parental
SHIVKU-1bMC33 in C8166 cells and electron microscopy
revealed differences in SHIVVpenv maturation compared to
parental SHIVKU-1bMC33
In an attempt to define the mechanism for the increased
SHIVVpenv release from infected cells, we examined infected
cultures by phase contrast and electron microscopy. Phase
contrast microscopy of cultures inoculated with SHIVVpenv
or SHIVKU-1bMC33 for 5 days revealed that SHIVVpenv
was more cytopathic than the parental SHIVKU-1bMC33
(data not shown). Because the p27 assays indicated thatthe SHIVVpenv-inoculated cultures released more virus into
the culture medium with time, we therefore examined cul-
tures inoculatedwith SHIVVpenv and parental SHIVKU-1bMC33
at 5 days post-inoculation by electron microscopy. As
shown in Fig. 5A, SHIVKU-1bMC33-inoculated C8166 cells
revealed viral particles maturing at the cell plasma mem-
brane. Enumeration of the number of virus particles associ-
ated with 100 infected cells resulted in an averaged of 25
particles per cell (Table 1). Examination of SHIVVpenv-
inoculated cultures by electron microscopy also revealed
virus maturing at the cell plasma membrane. In addition to
virus particles assembling at the surface of infected cells,
electron microscopy revealed numerous virus particles asso-
ciated with the cell plasma membrane (Figs. 5B and C) and
averaged 79 virus particles associated per cell (Table 1). The
observation of three times as many particles at the surface of
infected cells compared to parental SHIVKU-1bMC33 agreed
well with the results of the p27 growth curves. Additionally,
SHIVVpenv particles were frequently observed within intra-
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lular vesicles, which was not observed in SHIVKU-1bMC33-
infected cells (Fig. 5D).
SHIVVpenv replicates and causes severe loss of circulating
CD4+ T cells in pig-tailed macaques
To assess the role of the fused vpu and env genes in
CD4+ T cell loss in macaques, three pig-tailed macaques
(CT1R, CT1G, and CP3R) were inoculated with SHIVVpenv.
CD4+ T cell counts and viral loads were then monitored for
25 weeks (Fig. 6A). After inoculation with SHIVVpenv, the
circulating CD4+ T cell numbers in all three macaques
(CT1R, CT1G, and CP3R) dropped from 666 to 777 cells/
Al at week 0 to below 0–36 cells/Al by week 2. From 4
weeks to 24 weeks, CD4+ T cell numbers remained low,
below 22 cells/Al. Macaque CT1R had the lowest CD4+ T
cell counts, which were undetectable in four of seven bleeds
after the second week. All three macaques developed
chronic diarrhea starting at 16 weeks post-inoculation and
were euthanized at 25 weeks in a moribund condition. In
addition, macaque CT1R developed severe pneumonia as aFig. 6. SHIVVpenv is pathogenic for pig-tailed macaques. (Panel A)
Macaques were inoculated with SHIVVpenv and circulating CD4
+ T cells
determined at various times post-inoculation. (Panel B) Circulating CD4+ T
cell levels in macaques determined at various times post-inoculation with
parental SHIVKU-1bMC33.consequence of his infection. At the time of euthanasia,
CP3R, CT1R, and CT1G had circulating CD4+ T cell levels
of 18, 7, and 14 cells/Al, respectively. The circulating CD4+
T cell levels were similar to that seen in macaques inocu-
lated with parental SHIVKU-1bMC33 (Fig. 6B).
The mutation at the vpu–env junction was stable during the
initial phase of CD4+ T cell loss but reverted to the parental
SHIVKU-1bMC33 genotype in all three pig-tailed macaques by
12 weeks post-inoculation
The removal of a single nucleotide at the vpu–env
junction resulted in the fusion of the first 162 bases of
vpu to the env ORF. To assess the stability of this mutation,
the vpu was amplified from DNA isolated from the PBMCs
at various times post-inoculation and the sequences deter-
mined (Fig. 7). The sequence at the vpu–env junction was
found to be stable at 4 and 8 weeks post-inoculation, which
was the period of severe loss of circulating CD4+ T cells.
Analysis of the vpu sequences was also analyzed at later
time points after inoculation with SHIVVpenv. As shown in
Fig. 7, the vpu–env junction reverted to the SHIVKU-1bMC33
sequence (i.e., the A residue was repaired) in macaque
CT1G at 10 weeks post-inoculation (Fig. 8). A similar
reversion occurred in macaque CP3R and CT1R at 12 weeks
post-inoculation. The reversion to the SHIVKU-1bMC33 se-
quence was also seen at 16 weeks post-inoculation and a
mixture of both genotypes seen at 20 and 25 weeks. No other
consensus changes were noted in the vpu coding sequences.
These data indicate that there was a strong selective pressure
to repair this one base pair deletion resulting in shifting the
vpu gene into a different ORF from env. In addition to the
PBMC, we analyzed the sequences in the lymph nodes,
spleen, and thymus at necropsy (Table 2). A mixture of the
two genotypes was found in macaque CP3R, only the
SHIVKU-1bMC33 genotype found in the tissue DNA of
macaque CT1G and only the SHIVVpenv genotype was
detected in the lymphoid tissues from macaque CT1R. In
addition to the vpu sequence analysis, we also amplified and
sequenced the gp120 region of env from PBMC harvested at
4 and 8 weeks post-inoculation. We did not find any
consensus changes in the env gp120 sequences at these time
points, indicating that amino acid changes in the gp120
region of Env did not contribute to the observed pathogen-
esis of the SHIVVpenv in macaques CT1R, CT1G, and CP3R
(data not shown).
Virus loads in the macaques inoculated with SHIVVpenv are
similar to those inoculated with parental SHIVKU-1bMC33
macaques
Virus loads were monitored for 25 weeks post-inocula-
tion and at necropsy. Similar to previous studies, infectious
center assays (ICAs) detected the highest number of periph-
eral blood mononuclear cells (PBMCs) producing cytopath-







Fig. 7. Sequence analysis of the vpu–env junction from macaques inoculated with SHIVVpenv. The DNAwas iolated from PBMC of macaques at various times
post-inoculation. The vpu gene was amplified, isolated, and sequenced. Shown at the top are the sequence of the parental SHIVKU-1bMc33 and SHIVVpenv. The
deletion of the A residue is indicated by the ( ). A mixture of genotypes (SHIVKU-1bMC33 or SHIVVpenv) was indicated by a (B).
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spleen and lymph node (LN) (thymus cells could only
be isolated from macaque CP3R). Macaque CT1R and
CT1G showed the highest levels of cells producing virus,
both having 105 cells producing virus per 106 cells isolated
from the mesenteric LN and spleen. The number of cells
producing infectious virus from the same tissues derived
from macaque CP3R were lower (103 per 106 isolated
cells). In addition, the number of viral copies was assessed
using real-time RT-PCR (Fig. 8B) and showed similar
values to SHIVKU-1bMC33-inoculated macaques (Singh et
al., 2003). The PCR-ICA also reflected the high numbers
of infected cells in the spleen and lymph nodes from
macaques CT1R and CT1G (Fig. 8C). These virus loads
observed with the SHIVVpenv were similar to virus loads
previously reported with the parental SHIVKU-1bMC33
(Singh et al., 2003; Stephens et al., 2002).
The distribution of replicating virus and pathology in
SHIVVpenv-inoculated macaques was similar to macaques
inoculated with parental SHIVKU-1bMC33
Histological examination of the inguinal, axillary, and
mesenteric lymph nodes revealed depletion of the germinal
centers within these tissues (Fig. 9). Histological exami-nation of the spleen from all three animals revealed no
significant lesions. Examination of the thymus revealed
severe depletion and atrophy in macaques CT1R and
CT1G while the thymus from macaque CP3R had no
significant lesions. The finding of severe lymphoid deple-
tion in these tissues is similar to that reported for parental
SHIVKU-1bMC33 (Singh et al., 2003; Stephens et al., 2002).
No significant lesions were found in the heart, kidney,
liver, pancreas, and salivary glands. No lesions were found
in the lungs or CNS from macaques CP3R and CT1G.
Histological examination revealed that macaque CT1R
developed severe pneumonia consistent with Pneumocystis
carnii pneumonia (Fig. 9), astrocytosis in the CNS as
determined by enhanced immunoreactivity for glial fibril-
lary acidic protein (GFAP) and scattered microglial nod-
ules (data not shown). The distribution of virus in the
various visceral tissues was determined by PCR for viral
2-LTR sequences, which is indicative of ongoing replica-
tion of the virus. As shown in Figs. 10A–C, viral 2-LTR
sequences were detected in 7 of 13 tissues from CT1G, 7
of 13 tissues from CT1R, and 6 of 13 tissues from CP3R.
The majority of the tissue DNAs that were positive for the
presence of 2-LTR sequences were the lymphoid organs
(Figs. 10A–C). We also analyzed the DNA samples
isolated from 12 regions of the CNS for gag and 2-LTR
Table 2
Results of vpu sequence analysis from lymphoid tissues taken at necropsy
Tissue
Macaque Axillary LN Inguinal LN Mesenteric LN Spleen Thymus
CP3R Mix Mix Neg Neg Mix
CT1R Neg Neg Neg Neg Neg
CT1G Pos Pos Pos Pos Pos
Neg: no reversion to SHIVKU-1bMC33 detected.
Pos: reversion to SHIVKU-1bMC33 detected.
Mix: mixture of SHIVKU-1bMC33 and SHIVVpenv genotypes detected.
Fig. 8. Results of the infectious center assays and PCR-ICA on the PBMC
obtained at various times post-inoculation from macaques CT1G, CT1R,
and CP3R. (Panel A) Results of ICA measuring levels of cells producing
infectious cytopathic virus. (Panel B) Plasma viral RNA levels in macaques
inoculated with SHIVVpenv. Samples were subjected to real-time RT-PCR
and Taqman probe homologous to the SIV gag gene. Standard curves were
generated using five dilutions of viral RNA of known concentration. (Panel
C) Results of PCR-ICA analysis on DNA samples from spleen, lymph
node, and thymus.
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gag sequences in 6 of 12 regions of the CNS (Figs. 11A
and B). Only 1 region of these 12 gag positive regions was
also positive for 2-LTR sequences (data not shown). In
contrast, all 12 regions of the CNS from macaque CT1R
were positive for gag sequences and 6 of 12 (temporal
cortex, corpus callosum, thalamus, midbrain, medulla, andpons) were positive for the presence of 2-LTR sequences,
respectively (Figs. 11C and D).Discussion
In a previous study using a HIV-1 virus that did not
express a functional Vpu protein, it was shown that
infected cells contained intracytoplasmic vacuoles with
large numbers of immature virions and decreased release
of infectious virus (Klimkait et al., 1990). These observa-
tions suggested that Vpu played a role in increased virus
release. This increase has also been further shown to be
dependent on cell type and rate of cellular proliferation
(Deora and Ratner, 2001). These investigators showed that
Vpu expression increased the level of virus released from
non-dividing cells but was arrested by nocodazole or
mimosine treatment. However, these investigators did not
observe increased virus release in actively replicating cells.
The exact mechanism of enhanced virus release is still
unknown but studies have linked the transmembrane
domain of Vpu as essential to this function (Schubert et
al., 1996b). Although there is no sequence homology to
the viral ion channel M2 of influenza, it has been sug-
gested that Vpu might function as an ion channel because
there are similar domain structures within both proteins.
These similarities in structure were determined by analyz-
ing the hydropathy plots between Vpu and the M2 protein
of the Influenza A virus (Lamb et al., 1985; Strebel et al.,
1989). This idea was given further support when it was
shown that Vpu-formed ion channels that are selective for
monovalent cations (indiscriminately between K+ or Ca+),
showed some permeability for divalent cations, but was
not selective for monovalent anions (Ewart et al., 1996;
Schubert et al., 1996b). The region of Vpu responsible for
ion channel activity was localized exclusively to the
transmembrane domain (Schubert et al., 1996b). Further
evidence linking the ion channel activity to virus release
was demonstrated using the amiloride derivatives 5-(N,N-
hexamethylene) amiloride and 5-(N,N-dimethyl) amiloride.
Amiloride itself or amantadine (which normally block the
ion channel protein M2 of influenza) did not block activity
(Ewart et al., 2002).
In this study, we examined whether fusion of the first
54 amino acids of the Vpu to the Env protein could
Fig. 9. Pathology associated with SHIVVpenv infection. Hematoxylin and eosin stains of sections from the lung (Panels A and B), thymus (Panels C and D), and
mesenteric lymph node (Panels E and F) from macaque CTIR (Panels A, C, and E) and an uninoculated macaque (Panels B, D, and F).
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hypothesized that either the fusion of the two genes
would: (a) result in the synthesis of a precursor molecule
in which the signal peptide of the Env protein would be
cleaved resulting in the normal gp160 molecule and a
truncated Vpu protein that contained the Env signal
peptide attached at the carboxyl terminus; or (b) result
in the synthesis of two precursor molecules, one with
Vpu and the signal peptide of the Env protein attached to
the precursor resulting in a precursor with a higher
molecular mass as well as the normal gp160 molecule.
We were able to show the presence of two precursor
molecules, the gp160 and a unique Vpu–Env fusion
protein with a Mr of 175,000, which represents fusion
of the Vpu protein to the entire Env protein. One salient
feature of this study was that the two Env precursors
were synthesized in approximately equivalent amounts in
SHIVVpenv-infected cells. These results are discordant
with a previous study that showed that translation of
the Vpu was relatively weak compared to the Env
precursor protein (Schwartz et al., 1990) and suggestedthat leaky scanning of the Vpu/Env mRNA resulted in
increased Env precursor synthesis over the Vpu synthesis.
The advantage of our approach used in this study was
that we were able to utilize the same antibody (which has
no reactivity to the Vpu protein) to immune precipitate
the Vpu translation product and the Env translation
product in the context of the virus infection. While one
could argue that by deletion of the (A) at the 1 position
in the Vpenv gene resulted in a weaker translation
initiation signal (GCAATGG in the wild-type env to
GGCATGG in the Vpenv gene), we believe that removal
of this residue leaves the resulting translation initiation
signal in the same context with G residues at positions
3 and +4. On the basis of densitometric analysis, we
believe that the leaky scanning by the initiation complex
is initiating protein synthesis at the env AUG approxi-
mately 50% of the time. Because the gp175 precursor
could be immune precipitated with an antiserum directed
to the cytoplasmic domain of Vpu, this indicates that the
signal peptide of the Env was not cleaved, and we believe
this may be due to steric hindrance imposed by the Vpu
Fig. 10. Amplification of viral 2-LTR sequences from DNA samples of the visceral organs from macaques CP3R (Panel A), CT1G (Panel B), and CT1R (Panel
C). Sequences were amplified from tissue DNA samples obtained at necropsy as described in the Materials and methods and run on a 1.5% agarose gel and
stained with ethidium bromide. Order of the gels in Panels A–C. (Lane 1) Molecular weight markers. (Lane 2) Positive control. DNA from C8166 cells
infected for 48 h with SHIVVpenv. (Lane 3) Negative control. DNA from uninoculated C8166 cells. (Lane 4) Heart. (Lane 5) Kidney. (Lane 6) Liver. (Lane 7)
Lung. (Lane 8) Pancreas. (Lane 9) Salivary gland. (Lane 10) Axillary lymph node. (Lane 11) Inguinal lymph node. (Lane 12) Mesenteric lymph node. (Lane
13). Small intestine. (Lane 14) Spleen. (Lane 15) Tonsil. (Lane 16) Thymus. Amplification of the 2-LTR sequences results in a band of 361 base pairs in length.
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the Vpu and the Env protein signal sequences are not
cleaved, we believe the gp175 protein is probably an-
chored in the membrane three times (the other being the
hydrophobic transmembrane domain of the gp41). Anoth-
er interesting finding of this study is related to the
accumulation of SHIVVpenv within infected cells. The
parental SHIVKU-1bMC33 virus was shown to mature by
budding at the cell plasma membrane, which is similar in
SIV and HIV-infected T cells (Freed, 2002; Owens et al.,
1991). Examination of SHIVVpenv-infected cells also
revealed virus particles maturing at the cell plasma
membrane. However, unlike parental SHIVKU-1bMC33-
infected cells, we observed numerous intracellular vesicles
with virus (both mature and immature) particles and virus
maturing into intracellular vesicles. While we cannot rule
out the possibility that some of the virus within the
vesicles was due to endocytosis of particles from the
surface, electron microscopy revealed that some of virus
particles in these vesicles arose by virus maturation into
the vesicles. The maturation phenotype of SHIVVpenv is
similar to that reported for the Vpu-deleted HIV-1 (Klim-
kait et al., 1990). However, several lines of evidence
indicate that the phenotype is not exactly the same. First,
while we also observed the accumulation of virus par-
ticles within intracellular vesicles of cells inoculated with
a virus in which the entire Vpu coding sequence was
removed before the env gene (novpuSHIVKU-1bMC33), thelevels of particles are approximately half as seen in
SHIVVpenv-inoculated cultures (data not shown). Another
piece of data that suggests that the SHIVVpenv phenotype
is not the same as a Vpu deleted phenotype relates to the
ability to replicate in HeLa CD4+ cells. In a recent study,
it was shown that vpu deleted HIV-1 could not be
efficiently released in certain human cell types including
HeLa cells (Varthakavi et al., 2003). Similar to these
investigators, we found that novpuSHIVKU-1bMC33 did not
replicate well in HeLa CD4+ cells, whereas the parental
SHIVKU-1bMC33 and the SHIVVpenv replicated very well
(data not shown). While the mechanism(s) for the matu-
ration of the SHIVVpenv at intracellular membranes is
currently unknown, it must undoubtedly involve the
gp175 protein as this virus is isogenic with parental
SHIVKU-1bMC33 except for the single deletion at the
vpu–env junction. It is possible that the gp160 and
gp175 proteins, which are being synthesized in approxi-
mately equivalent amounts, may form oligomeric struc-
tures and that these oligomers are capable of initiating the
budding process at intracellular membranes. Whether this
is due to the Vpu component of oligomers or that the
gp175, by virtue of the three transmembrane domains,
may not be as efficiently transported as the gp160, is
currently unknown. The maturation of both HIV-1 and
SIV in macrophages occurs at intracellular vesicles (Oren-
stein et al., 1988; Stephens et al., 1995b) and recently it
was shown that HIV-1 virus particles were found to
Fig. 11. Amplification of viral gag sequences from DNA samples of 12 regions of the brain macaques CP3R (Panel A), CT1G (Panel B), and CT1R (Panel C)
and 2-LTR sequences from the same CNS regions of macaque CT1R (Panel D). Order of the gels in Panels A–D. (Lane 1) One hundred base pair molecular
weight markers. (Lane 2) Positive control. DNA from C8166 cells infected for 48 h with SHIVVpenv. (Lane 3) Negative control. DNA from uninoculated C8166
cells. (Lane 4) Frontal cortex. (Lane 5) Motor cortex. (Lane 6) Parietal cortex. (Lane 7) Occipital cortex. (Lane 8) Temporal cortex. (Lane 9) Corpus callosum.
(Lane 10) Basal ganglia. (Lane 11) Thalamus. (Lane 12) Midbrain. (Lane 13) Pons. (Lane 14) Medulla. (Lane 15) Cerebellum. Amplification of the 2-LTR
sequences results in a band of 361 base pairs in length and gag sequences results in a band of 240 base pairs in length.
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and CD63, suggesting that these vesicles were consistent
with multivesicular bodies (MVB) (Raposo et al., 2002).
On the basis of our observations that SHIVVpenv is
efficiently assembled into intracellular vesicles, it will
be of interest to determine if SHIVVpenv will more
efficiently produce infectious viruses in macrophage cul-
tures and if intracellular maturation is restricted to MVB
or if the virus matures at other intracellular sites such as
the rough endoplasmic reticulum (RER) and/or Golgi
complex. Another feature of the SHIVVpenv is that many
of the virus particles appear to remain cell associated. The
results of the electron microscopy studies indicate that
despite extensively washing of SHIVVpenv-infected cells,
many particles can be visualized on the cell surface
compared to the parental virus SHIVKU-1bMC33.
The insertion of the fused vpu–env gene within the
SHIVKU-1bMC33 genetic background permitted the analysis
of its pathogenicity in a macaque model. Previously, we
showed that the Vpu enhances the pathogenicity of
SHIVKU-1bMC33 in pig-tailed macaques (Singh et al.,
2001; Stephens et al., 2002) but that the lack of a Vpu
could be compensated for with changes in other viralproteins such as Env and Nef (McCormick-Davis et al.,
2000; Singh et al., 2001). More recently, we showed that
removal of the casein kinase II sites in Vpu, which
previous studies have shown to be essential to the
interaction of Vpu with CD4 (Paul and Jabbar, 1997),
contributes to the severe CD4+ T cell loss observed
following inoculation with SHIVKU-1bMC33 (Singh et al.,
2003). Three pig-tailed macaques were intravenously
inoculated with SHIVVpenv to assess the pathogenicity of
this virus. All three animals developed severe CD4+ T
cell loss within 4 weeks post-inoculation, and cells
producing infectious virus were recovered throughout
the course of infection. Sequence analysis of the vpu
gene amplified from PBMC at different times after
inoculation (4, 6, and 8 weeks) revealed that during the
initial period of CD4+ T cell loss, the deletion at the vpu–
env junction was maintained. However, at subsequent
periods, we found that the sequence at the vpu–env
junction reverted back to that of parental SHIVKU-1bMC33.
These observations indicate that the fusion of the vpu and
env genes can still result in a severe loss in CD4+ T cell
loss early after inoculation similar to the CD4+ T cell loss
seen with the parental SHIVKU-1bMC33. However, our results
D.R. Hout et al. / Virology 323 (2004) 91–107102indicate that there is a selection toward having the vpu and
env genes in separate open reading frames. In addition to the
vpu genotype amplified from PBMC, we also analyzed the
vpu sequence from the three lymphoid tissues (lymph nodes,
spleen, and thymus). In one macaque, CT1G, we were able
to detect only the SHIVKU-1bMC33 genotype, whereas in
another macaque, CP3R, we were able to detect both
genotypes. In these macaques, there appeared to be a gradual
selection of the SHIVKU-1bMC33 over the SHIVVpenv geno-
type, which emphasizes the importance of an intact Vpu in
the pathogenesis of this virus in pig-tailed macaques.
On the basis of the observed pathogenicity of SHIVVpenv
in the macaques in this study and the non-pathogenic
nature of the novpuSHIVKU-1bMC33 (Stephens et al.,
2002), the mechanistic question arises as to ‘‘Why was
SHIVVpenv able to cause disease in macaques?’’ We have
shown that while SHIVVpenv produces two Env precursor
proteins (gp175 and gp160) in approximately equivalent
amounts, only gp120 appeared to be present in extracel-
lular virus. We hypothesize that the gp175 precursor,
which may span the membrane multiple times (once with
the uncleaved leader sequence of Vpu protein, once with
the now uncleaved leader sequence of Env, and the
transmembrane domain of gp41), is probably folded
improperly and hence defective in transport to the cell
surface but is still capable of interacting with the CD4
receptor in the RER. Such an interaction could free gp160
molecules to properly oligomerize, be transported to and
processed into gp120/gp41 within the Golgi complex and
finally be transported to the cell plasma membrane where
it could be incorporated into maturing virus particles.
Thus, the gp175 precursor would act similarly to an
intact Vpu protein in that it would prevent the gp160
precursor from interacting with CD4 in the RER. This
would abrogate the need for Vpu/CD4 interactions via the
casein kinase II sites. The other salient phenotypic char-
acteristic of SHIVVpenv is the ability to undergo matura-
tion at intracellular vesicles. Because the only difference
between SHIVKU-1bMC33 and SHIVVpenv is the removal of
a single nucleotide at the vpu–env junction, it suggests
that the gp175 protein may be involved in the altered
maturation process. While this mechanism of maturationT A C A TGTAATGCAACCTATACCAATAGTAGCAATAGTAGCATTAGTAGTAGCAA
Fig. 12. The sequence of the vpu–env junction in the parental SHIVKU-1bMC33 and
site-directed mutagenesis in the construction of SHIVVpenv. The asterisks over this unknown, the large numbers of viral particles that we
observe in intracellular vesicles could contribute to the
viral loads in the macaques and ultimately the loss of
circulating CD4+ T cells.Materials and methods
Cells, plasmids, and viruses
The lymphocyte C8166 cell line was used for trans-
fections as well as indicator cells to measure infectivity
and cytopathicity of the viruses used in this study. C8166
cells were maintained in RPMI-1640, supplemented with
10 mM Hepes buffer pH 7.3, 2 mM glutamine, 5 Ag/ml
gentamicin and 10% fetal bovine serum (R10FBS). The
derivation of SHIVKU-1bMC33 has been previously de-
scribed (McCormick-Davis et al., 2000; Stephens et al.,
2002).
Construction of SHIVVpenv
A virus was constructed in which a single nucleotide was
removed from the vpu–env junction (Fig. 12). Plasmid
pUC19DSNvpu12, containing the SphI to KpnI fragment
of SHIVKU-1bMC33 in pUC-19 (and coding for the tat, rev,
vpu and 5V end of env) was used for the site-directed
mutagenesis studies. The mutagenesis was performed using
oligonucleotides 5V-GAGCAGAAGACAGTGGCATGA-
GAGTGAAGGAG-3V (sense) and 5V-GTCCTTCACTCT-
CATGCCACTGTCTTCTGCTC-3 V(antisense). The
plasmid used was pUC19DSNvpu12 and the Quick-Change
Mutagenesis Kit (Stratagene) according to the manufactur-
er’s instructions. Clones were isolated, plasmids isolated,
and the entire insert sequenced to determine if the mutations
were introduced as expected and to ensure that no additional
changes were introduced during the mutagenesis step. A
plasmid was isolated and designated as pVpuVpenv that
contained the desired mutation. This plasmid was digested
to completion with SphI/KpnI, the 450-base pair fragment
isolated, and subcloned into the p3VSHIVKU-1bMC33 plasmid
as previously described (McCormick-Davis et al., 2000).TAATAATAGCAATAGTTGTGTGGTCCATAGTAATCATAGAATATAGG
SHIVVpenv. The arrow represents the adenine residue that was eliminated by
e serine represent the phosphorylation sites.
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an infectious virus known as SHIVVpenv using procedures
previously described (Liu et al., 1999; McCormick-Davis et
al., 2000; Singh et al., 2002; Stephens et al., 1998). Stocks
of the virus were prepared and titered in C8166 cells. The
virus stock was examined by PCR amplification of the vpu
gene sequence and sequence analysis to ensure the purity of
the stock virus.
Pulse-chase analysis of viral proteins
To determine if viral structural proteins were released
with reduced efficiency in SHIVVpenv-inoculated cultures,
C8166 cells were inoculated with 103 TCID50 of either
SHIVVpenv or SHIVKU-1bMC33. At 5 days post-infection,
the medium was removed and infected cells were incubat-
ed in methionine/cysteine-free Dulbecco’s modified
Eagle’s medium (DMEM) for 2 h. The cells were then
radiolabeled for 30 min with 1 mCi/ml 35S-Translabel
(methionine and cystine, ICN Biomedical, Costa Mesa,
CA) and the radiolabel chased for various periods of time
in DMEM containing 100 unlabeled methionine/cysteine.
SHIV proteins were immune precipitated from the cell
culture medium and infected cell lysates using plasma
pooled from several rhesus monkeys infected previously
with SHIVKU-1. Briefly, the cell culture medium was
clarified (16,000  g) for 2 min. The supernatant was
transferred and made 1 with respect to RIPA buffer (50
mM Tris–HCl, pH 7.5; 50 mM NaCl; 0.5% deoxycholate;
0.2% SDS; 10 mM EDTA) and SHIV proteins were
immune precipitated with 10 Al of a pooled serum from
several monkeys that were inoculated with non-pathogenic
SHIV for over 1 year. For immune precipitation of cell-
associated SHIV proteins, cell lysates were prepared as
described previously (McCormick-Davis et al., 2000; Ste-
phens et al., 1995a, 1997) before incubation with antise-
rum. Lysates were centrifuged in a microfuge to remove
nuclei before the addition of antibody. Cell lysates and
culture medium were incubated with antibody for 16 h at
4jC. All immune precipitates were collected on protein A-
Sepharose, the beads were washed three times with RIPA
buffer, and the samples resuspended in sample reducing
buffer. Samples were boiled and the SHIV-specific proteins
analyzed by SDS-PAGE. Proteins were then visualized by
standard autoradiographic techniques.
p27 assays
Standard p27 assays (Coulter) were used to assess release
of viral particles from cells infected with SHIVVpenv or
parental SHIVKU-1bMC33. Virus stocks were titered by
performing a series of 10-fold dilutions in medium without
serum and then inoculating a HeLaCD4+ cell line that
expresses the green fluorescent protein (GFP) under the
control of the HIV-1 LTR. At 48 h after inoculation, the
number of fluorescent cells (indicative of infection by thevirus and subsequent expression of the GFP) were scored
and titers determined. Cultures of 106 C8166 cells were
inoculated with equivalent amounts of infectious cell-free
virus (1  103; multiplicity of infection of 0.001) for 4 h.
At the end of 4 h, the cells were centrifuged at 400  g for
10 min and the pellet washed with 10 ml of medium. This
was repeated two additional times. The cells were resus-
pended in RPMI-1640 supplemented with 10% FBS and
antibiotics and this was considered the 0 time point of the
assay. Cultures were incubated at 37jC and aliquots of the
culture were removed at 0, 1, 3, 5, 7, and 10 days with
fresh media added to cultures at days 3, 5, and 7. The
culture medium was separated from the cells by centrifu-
gation and assayed for p27 according to the manufacturer’s
instructions.
Electron microscopy
To determine the site of intracellular maturation,
infected cells were examined by electron microscopy.
Cultures of C8166 cells were inoculated with SHIVKU-
1bMC33 or SHIVVpuenv at a multiplicity of infection of 0.01.
Cells were incubated for a total of 5 days at which time
cells were pelleted at 400  g for 10 min. Cells were
washed four times with 10 ml of phosphate-buffered saline
(pH 7.4) and then fixed in 2% glutaraldehyde overnight at
4jC. Cells were postfixed in 1% osmium tetroxide (OsO4)
for 1 h. The cells were washed twice with water and
dehydrated through a series of alcohols (30–100%) and
the cells were embedded in Embed 812 resin. Thin
sections were cut at 80 nm, stained with uranyl acetate
and lead citrate, and examined under a JEOL 100CXII
transmission electron microscope.
For enumeration of virus particles on the surface of
cells, C8166 cultures were inoculated with equivalent
amounts of SHIVVpenv or SHIVKU-1bMC33 for 5 days and
cultures processed as described above. The number of
particles associated with 100 different cells and the mean
number of particles calculated per infected cell were
determined.
Macaques analyzed in this study
Three pig-tailed macaques (CT1R, CT1G, and CP3R)
were inoculated intravenously with 1 ml of undiluted super-
natant from C8166-grown stocks of SHIVVpuenv containing
approximately 104 TCID50 per milliliter. These macaques
were euthanized at 25 weeks following inoculation. The
inoculated macaques were compared with macaques inocu-
lated with pathogenic SHIVKU-1bMC33 and those inoculated
with novpuSHIVKU1bMC33 as previously described (Singh et
al., 2003; Stephens et al., 2002). The animals were housed in
the AAALAC-approved animal facility at the University of
Kansas Medical Center. Heparinized blood was collected
weekly for 4 weeks, at 2-week intervals for the next month,
and thereafter at monthly intervals.
ology 323 (2004) 91–107Processing of blood samples
The PBMCs were prepared by centrifugation on Ficoll-
Hypaque gradients as described previously (Joag et al.,
1996). Ten-fold dilutions of PBMCs (106 cells/ml) were
inoculated into replicate cultures and were examined for
development of cytopathic effects as previously described
(McCormick-Davis et al., 2000). The number of cells
producing infectious, cytopathic virus in the blood were
reported as the number of infected cells per106 cells.
Alterations in the levels of CD4+ lymphocytes after exper-
imental inoculations were monitored sequentially by FACS
analysis (Becton Dickinson). T lymphocyte subsets were
labeled with OKT4 (CD4; Ortho Diagnostics Systems, Inc.),
SP34 (CD3; Pharmingen), or FN18 (CD3; Biosource Inter-
national) monoclonal antibodies. T lymphocyte subsets
from a normal uninfected macaque were always performed
at the same time as inoculated macaques as a control for the
FACS analysis.
Processing of tissue samples at necropsy
At the time of euthanasia, all animals in this study were
anesthetized by administration of 10 mg/kg ketamine (IM)
followed by an intravenous administration of sodium pen-
tobarbital at 20–30 mg/kg. A laparotomy was performed on
the animal exsanguinated by aortic canulation. The chest
was opened, the left ventricle canulated, the right atrium
nicked, and the animal perfused with 1 l of cold pyrogen-
free Ringer’s saline. All aspects of the animal studies were
performed according to the institutional guidelines for
animal care and use at University of Kansas Medical Center.
At necropsy, tissues from the lymph nodes (axillary, ingui-
nal, and mesenteric), heart, kidney, liver, lungs, pancreas,
small intestine, spleen, and thymus, were fixed in 10%
neutral buffered formalin and embedded in paraffin. Sec-
tions (5 Am) were stained with hematoxylin and eosin for
routine histological examination. In addition, the right half
of the brain and spinal cord were dissected into frontal,
motor, parietal, temporal and occipital cortices, corpus
callosum, thalamus, basal ganglia, midbrain, pons, medulla,
cerebellum, cervical, thoracic and lumbar spinal cord and
were also processed as above. In addition, pieces of each of
the visceral organs and regions of the CNS were frozen in
liquid nitrogen for DNA isolation and molecular virological
analysis.
PCR amplification and sequence analysis of vpu and env
vpu
At various times post-inoculation, the vpy-env junction
was examined by sequence analysis to determine if the
deletion was maintained. DNA was extracted from PBMC
and visceral organs, as previously described (McCormick-
Davis et al., 2000) and 1 Ag of this DNA was used in the
nested PCR to amplify the vpu gene as described previ-
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the first round of amplification were the 5V-CCTAGAC-
TAGAGCCCTGGAAGCATCC-3V (sense) corresponding
to the region 5845–5870 located upstream of the vpu
region and 5V-GTACCTCTGTATCATATGCTTTAGCAT-3V
(antisense) corresponding to the region 6393–6420 down-
stream. The second round of amplification was performed
using the oligonucleotide primers 5V-TTAGGCATCTCC-
TATGGCAGGAAGAAG-3V (sense) and 5V-CACAAAA-
TAGAGTGGTGGTTGCTTCCT-3V which are com-
plementary to nucleotides 5956–5984 and 6386–6413
of the HIV-1 (HXB2) genome. The PCR amplification
was performed using the following conditions: denatur-
ation at 92jC for 1 min, annealing at 55jC for 1 min,
and primer extension at 72jC for 3 min. To increase the
amount of template for sequencing, 1 Al of the first PCR
product was used as a template for a second amplification
using the same conditions. For sequence analysis of
genes, the PCR products from three separate PCRs were
separated by electrophoresis in a 1% agarose gel. The
desired DNA fragments were excised from gels and
purified using a Millipore Ultrafree MC centrifugal filter
device. The isolated PCR product was used in cycle
sequencing reactions using the BigDye Terminator Cycle
Sequencing Ready Reaction Kit with AmpliTaq DNA
polymerase, FS (PE Applied Biosystems, Foster City,
CA), sequence detection was conducted with Applied
Biosystems 377 Prism XL automated DNA sequencer,
and visualized using the ABI Editview program. Sequen-
ces were compared to the wild-type vpu sequences from
SHIVKU1b-MC33 using the Omiga 2.0 sequence analysis
software program. If direct sequencing revealed changes
at the vpu–env junction, they were confirmed by cloning
into the pGEMT-Easy Vector according to the manufac-
turer’s instructions followed by sequencing of the vpu
inserts.
SHIV env
The gp120 region of env was sequenced to determine
if any consensus changes occurred in gp120 during the
early periods (4, 9, and 12 weeks) after inoculation with
SHIVVpuenv DNA was isolated from PBMC was used in
PCR amplification using oligonucleotide primers (Singh et
al., 2002). The conditions for amplification and cloning of
the PCR products were the same as described above.
SHIV gag
DNA extracted from the visceral organs and different
regions of the CNS as previously described (McCormick-
Davis et al., 2000) was used to amplify viral gag sequences.
The oligonucleotides used for the first round of amplification
were the 5V-GATGGGCGTGAGAAACTCCGTCTT-3V
(sense) and 5V-CCTCCTCTGCCGCTAGATGGTGCT-
GTTG-3V (antisense) corresponding to the region 1052–
1075 and 1423–1450 of the SIVmac239 gag gene, respec-
tively (Regier and Desrosiers, 1990). The fourth exon of
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oligonucleotides primers, 5V-TACTGTTTGAGACCTT-
CAACACCCAG-3V (sense) and 5V-CCAAGAAGGAAGG-
CTGGAAGACTGCC-3V (antisense), which are comp-
lementary to the published sequence (Nakijima-Iijima et
al., 1985). The nested SIVmac239 primers used were 5V-
GTTGAAGCATGTAGTAGTGGCAGC-3V (sense) and 5V-
CACCACTAGG-TGTCTCTGCACTATCTG-3V (antisense)
which are complementary to bases 1142–1165 and 1356–
1382 of SIVmac239, respectively. The nested h-actin primers
used were 5V-CCCCAGCCATGTACGTTGCTATCC-3V
(sense) and 5V-GCCTCAGGGCAGCGGAACCGCTCA-3V
(antisense). The conditions for amplification and cloning of
the PCR products were the same as described above.
Long terminal repeat circles
We examined tissue DNA samples for the presence of 2-
LTR circular DNA as it provides a view of a spreading
infection based on a viral DNA form that is structurally
distinct and known to have a short half-life in infected cells
(Sharkey and Stevenson, 2001; Sharkey et al., 2000; Teo et
al., 1997; Zazzi et al., 1997;). DNA isolated from visceral
organs and 12 regions of the brain was analyzed for the
presence of 2-LTR circular forms of DNA as previously
described (McCormick-Davis et al., 2000). The oligonucleo-
tides used in the first round were 5V-CCTCCTG-
TGCCTCATCTGATACATTTAC3V (U5 region) and 5V-
ATTTCGCTCTGTATTCAGTCGCTCTGC-3V (U3 region),
which correspond to bases 10,335 to 10,361 and 180 to 153 of
the SHIV genome, respectively. The PCR amplification was
performed using the following conditions: denaturation at
92jC for 1 min, annealing at 55jC for 1 min, and primer
extension at 72jC for 3 min. One microliter of the first PCR
product was used as a template for a second amplification
using the same conditions. The oligonucleotide primers used
for the second round were 5V-TTGGGTATCTAATT-
CCTGGTCCTGAG-3V (U5 region) and 5V-AGGTTCTCTC-
CAGCACTAGCAGGTAGAGC-3V (U3 region; opposite
strand; 456), which corresponds to bases 10,389 to 10,417
and 120 to 95 of the SHIV genome, respectively. The
predicted product of the 2-LTR PCR product is 361 base
pairs.
Analysis of virus loads in macaques
PCR-ICA
The virus loads in the CNS and lymphoid tissues were
determined using a quantitative PCR assay modified from a
PCR-infected cell assay previously described (Joag et al.,
1994; Stephens et al., 1998). In this assay, 1 Ag of total
cellular DNA isolated from tissues was subjected to a series
of 10-fold dilutions such that samples contained from 100
ng to 10 fg (less than one copy of chromosomal DNA).
These samples were used in nested PCR reactions that
amplified either the h-actin gene of the cell (a single copy
gene) or the gag gene from SHIVKU1bMC33. Amplificationof either gene using the primers previously described was
shown to detect one of the copy of each gene (Joag et al.,
1994). Thus, amplification of the h-actin gene determined
the number of genome equivalents in each sample, whereas
amplification with the gag primers determined the number
of viral copies per number of genome equivalents. The
values were expressed as the number of viral copies per 106
genome equivalents.
Plasma virus loads
Plasma viral RNA loads were determined on RNA
extracted from 500 Al of EDTA-treated plasma. Virus was
pelleted and RNA extracted using the Qiagen viral RNA kit
(Qiagen, Valencia, CA). RNA samples were analyzed by
real-time RT-PCR using gag primers and a 5VFAM and
3VTAMRA labeled Taqman probe that was homologous to
the SIV gag gene as previously described (Hofmann-Leh-
mann et al., 2000). Standard curves were prepared using a
series of six 10-fold dilutions of viral RNA of known
concentration. The sensitivity of the assay was 100 RNA
equivalents per milliliter. Samples were analyzed in tripli-
cate and the number of RNA equivalents were calculated
per milliliter of plasma.Acknowledgments
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